Professor and Director of CCIT (Center for Cancer Immune Therapy) at Herlev University Hospital. IMS has extensive experience in clinical translation of immune therapies and is an advisor for several large pharma companies. Currently running a phase III trial

Professor, MD, Ph.D. Inge Marie Svane
Founder, Clinical Advisor